Literature DB >> 16971294

Factors affecting attrition in a longitudinal study of patients with AIDS.

D M Brown1, J E Thorne, G L Foster, J L Duncan, L M Brune, A Muñana, C L Meinert, D A Jabs.   

Abstract

Anecdotal data have suggested that retention of HIV-infected patients with immune recovery in longitudinal studies may be difficult as they resume normal activities. This study evaluated risk factors for attrition among patients with AIDS in a cohort study in the era of highly active antiretroviral therapy. Patients with AIDS enrolled in the Longitudinal Study of Ocular Complications of AIDS were evaluated every three months with demographic, clinical and laboratory data collected. Lost to follow-up was defined as any patient who missed all study visits and could not be contacted for 12 consecutive months, who had not died and who did not re-enter the study at a later date. Of the 1,052 patients studied, 77 (7.3%) were lost to follow-up (rate = 0.03/person year). In the multivariate analysis, factors associated with attrition were CD4+ T-cell count category (hazard ratio (HR) = 2.03; 95%CI: 1.01, 4.24; P = 0.05 for CD4+ count < or = 50 cells/microL and HR = 1.96; 95%CI: 1.12, 3.40; P = 0.02 for CD4+ count 51-200 cells/microL) and detectable HIV viral load (HR = 1.29; 95%CI: 1.07, 1.53; P < 0.001 for HIV viral load >400 copies/mL). These data suggest that patients with compromised immunologic status are at an increased risk for being lost to follow-up.

Entities:  

Mesh:

Year:  2006        PMID: 16971294     DOI: 10.1080/09540120500466747

Source DB:  PubMed          Journal:  AIDS Care        ISSN: 0954-0121


  16 in total

1.  Predictors of Attrition in a Cohort Study of HIV Infection and Methamphetamine Dependence.

Authors:  J Cattie; M J Marquine; K A Bolden; L C Obermeit; E E Morgan; D R Franklin; A Umlauf; J M Beck; J H Atkinson; I Grant; S P Woods
Journal:  J Subst Use       Date:  2015-02-03

Review 2.  Attrition and related trends in scientific rigor: a score card for ART adherence intervention research and recommendations for future directions.

Authors:  K Rivet Amico; Jennifer J Harman; Megan A O'Grady
Journal:  Curr HIV/AIDS Rep       Date:  2008-11       Impact factor: 5.071

3.  Special diabetes program for Indians: retention in cardiovascular risk reduction.

Authors:  Spero M Manson; Luohua Jiang; Lijing Zhang; Janette Beals; Kelly J Acton; Yvette Roubideaux
Journal:  Gerontologist       Date:  2011-06

4.  Stimulant Use and Study Protocol Completion: Assessing the Ability of Men Who Have Sex with Men to Collect Dried Blood Spots for Laboratory Measurement of HIV Viral Load.

Authors:  Richard A Teran; Adam W Carrico; Keith J Horvath; Martin J Downing; Mary Ann Chiasson; Suzan M Walters; Sabina Hirshfield
Journal:  Arch Sex Behav       Date:  2019-10-19

5.  Participant and site characteristics related to participant retention in a diabetes prevention translational project.

Authors:  Luohua Jiang; Spero M Manson; Edward J Dill; Janette Beals; Ann Johnson; Haixiao Huang; Kelly J Acton; Yvette Roubideaux
Journal:  Prev Sci       Date:  2015-01

6.  Incidence rate of and factors associated with loss to follow-up in a longitudinal cohort of antiretroviral-treated HIV-infected persons: an AIDS Clinical Trials Group (ACTG) Longitudinal Linked Randomized Trials (ALLRT) analysis.

Authors:  S Krishnan; K Wu; M Smurzynski; R J Bosch; C A Benson; A C Collier; M K Klebert; J Feinberg; S L Koletar
Journal:  HIV Clin Trials       Date:  2011 Jul-Aug

7.  Determinants of retention in care in an antiretroviral therapy (ART) program in urban Cameroon, 2003-2005.

Authors:  Landry Tsague; Sinata S Koulla; Alain Kenfak; Charles Kouanfack; Mathurin Tejiokem; Therese Abong; Madeleine Mbangue; Yacouba Njankouo Mapoure; Claudine Essomba; Jembia Mosoko; Regis Pouillot; Louis Menyeng; Helene Epee; Carno Tchuani; Anne Cecile Zoung-Kanyi; Lucienne Assumpta Bella; Leopold Zekeng
Journal:  Pan Afr Med J       Date:  2008-07-04

8.  Association of site-specific and participant-specific factors with retention of children in a long-term pediatric HIV cohort study.

Authors:  Paige L Williams; Russell Van Dyke; Michelle Eagle; Dorothy Smith; Carol Vincent; Gregory Ciupak; James Oleske; George R Seage
Journal:  Am J Epidemiol       Date:  2008-04-15       Impact factor: 4.897

9.  Risk of cataract among subjects with acquired immune deficiency syndrome free of ocular opportunistic infections.

Authors:  John H Kempen; Elizabeth A Sugar; Rohit Varma; James P Dunn; Murk-Hein Heinemann; Douglas A Jabs; Alice T Lyon; Richard A Lewis
Journal:  Ophthalmology       Date:  2014-08-08       Impact factor: 12.079

10.  Cost-effectiveness of preventing loss to follow-up in HIV treatment programs: a Côte d'Ivoire appraisal.

Authors:  Elena Losina; Hapsatou Touré; Lauren M Uhler; Xavier Anglaret; A David Paltiel; Eric Balestre; Rochelle P Walensky; Eugène Messou; Milton C Weinstein; François Dabis; Kenneth A Freedberg
Journal:  PLoS Med       Date:  2009-10-27       Impact factor: 11.069

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.